<DOC>
	<DOC>NCT01799031</DOC>
	<brief_summary>This randomized clinical trial studies an educational intervention for reducing work disability in breast cancer survivors. Web sites providing symptom management education may be an effective method to help breast cancer survivors reduce work disability after treatment</brief_summary>
	<brief_title>Educational Intervention for Reducing Work Disability in Breast Cancer Survivors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES: I. Determine the feasibility and usability of the Work Ability Improvement Through Symptom Management and Ergonomic Strategies (WISE) and empirically evaluate its effect on short-term work ability among breast cancer survivors (BCS). SECONDARY OBJECTIVES: I. Explore individual and workplace factors associated with work ability in BCS. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications. Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights. ARM II: Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights. After completion of study treatment, patients are followed up at 3 and 6 months.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Diagnosed with breast cancer Employed at time of cancer diagnosis (defined as paid employment &gt; 20 hours/week) Within six months of completion of active treatment Working during treatment or intending to return to work following active treatment Computer and internet access Patients who do not intend to continue/resume working following treatment Develop distant metastases or progressive disease Prior diagnosis of malignancy at any other site except for in situ carcinomas of the cervix or nonmelanomatous skin cancers</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>